Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-03-06
DOI
10.3389/fimmu.2020.00264
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of PD-1 during effector CD8 T cell differentiation
- (2018) Eunseon Ahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Precision Immunotherapy for Sepsis
- (2018) Annemieke M. Peters van Ton et al. Frontiers in Immunology
- Evaluating antidisease immunity to malaria and implications for vaccine design
- (2017) Temitope W. Ademolue et al. IMMUNOLOGY
- A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII
- (2017) Takayuki Shiratsuchi et al. VACCINE
- Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8 + T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells
- (2016) Jordana G. Coelho-dos-Reis et al. CLINICAL IMMUNOLOGY
- Regulation of the host immune system by helminth parasites
- (2016) Rick M. Maizels et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Modeling of protein–peptide interactions using the CABS-dock web server for binding site search and flexible docking
- (2016) Maciej Blaszczyk et al. METHODS
- Sepsis and septic shock
- (2016) Richard S. Hotchkiss et al. Nature Reviews Disease Primers
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
- (2015) Theo Vos et al. LANCET
- CABS-dock web server for the flexible docking of peptides to proteins without prior knowledge of the binding site
- (2015) Mateusz Kurcinski et al. NUCLEIC ACIDS RESEARCH
- Looking beyond the induction of Th2 responses to explain immunomodulation by helminths
- (2015) T. B. Nutman PARASITE IMMUNOLOGY
- Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1
- (2015) Krzysztof M. Zak et al. STRUCTURE
- Gaps in knowledge and prospects for research of adjuvanted vaccines
- (2015) Robert Seder et al. VACCINE
- T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance
- (2015) B Ye et al. Cell Death & Disease
- Shortcomings of pertussis vaccines: why we need a third generation vaccine
- (2014) Jan T Poolman Expert Review of Vaccines
- Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation
- (2014) Bertram Bengsch et al. JOURNAL OF HEPATOLOGY
- PD-1 Blockade in Rhesus Macaques: Impact on Chronic Infection and Prophylactic Vaccination
- (2014) A. C. Finnefrock et al. JOURNAL OF IMMUNOLOGY
- Impairment of T Cell Function in Parasitic Infections
- (2014) Vasco Rodrigues et al. PLoS Neglected Tropical Diseases
- Malaria drives T cells to exhaustion
- (2014) Michelle N. Wykes et al. Frontiers in Microbiology
- Unraveling the complexity of hepatitis B virus: From molecular understanding to therapeutic strategy in 50 years
- (2013) Bo Liu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Structure and Interactions of the Human Programmed Cell Death 1 Receptor
- (2013) Xiaoxiao Cheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: Experiences and findings
- (2013) Dao-Zhen Xu et al. JOURNAL OF HEPATOLOGY
- Cytokine Profiling in Immigrants with Clinical Malaria after Extended Periods of Interrupted Exposure to Plasmodium falciparum
- (2013) Gemma Moncunill et al. PLoS One
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockage Reverses Immune Dysfunction and Hepatitis B Viral Persistence in a Mouse Animal Model
- (2012) Horng-Tay Tzeng et al. PLoS One
- Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells
- (2011) M. K. L. MacLeod et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+ T Cells Is Linked to Antigen Recognition and T Cell Differentiation
- (2010) Bertram Bengsch et al. PLoS Pathogens
- Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
- (2009) Paola Fisicaro et al. GASTROENTEROLOGY
- Loss of Population Levels of Immunity to Malaria as a Result of Exposure-Reducing Interventions: Consequences for Interpretation of Disease Trends
- (2009) Azra C. Ghani et al. PLoS One
- PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis
- (2009) X. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started